What is HBM Holdings Limited?
HBM Holdings Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
HBM Holdings Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally. It develops the Harbour Mice Platform, which generates human monoclonal antibodies in two heavy and two light chain H2L2 and heavy chain formats. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.30B, and a P/E ratio of 17.3x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.